FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E

EXPLORE DATA
VISUALIZATIONS

Explore key data on health and its determinants in India through interactive graphs.

Opportunities for Typhoid Vaccination in India

28 Jun 2023
Emerging Pandemics

by Perspective 6 MIN

In this study, the need for typhoid immunisation in India is examined, and the effectiveness, immunogenicity, and cost-effectiveness of the typhoid vaccines that are currently on the market are evaluated. The first typhoid conjugate vaccine Vi-TT was prequalified by the WHO in 2018 and recommended for children aged 6-23 months, coupled with the measles vaccination at 9 or 15 months through the increased immunisation programme. Typhoid vaccination should be explored as soon as possible given the significant endemicity of the disease in India and the conjugate vaccine's shown cost-effectiveness.

Categories

Data
KEY ORGANIZATIONS
Connect with Us

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2026 Swasti Health Catalyst